54
Views
12
CrossRef citations to date
0
Altmetric
Original Research

Expression and prognostic value of GalNAc-T3 in patients with completely resected small (≤2 cm) peripheral lung adenocarcinoma after IASLC/ATS/ERS classification

, , , , , & show all
Pages 3143-3152 | Published online: 27 Oct 2015

References

  • SiegelRWardEBrawleyOJemalACancer statistics, 2011CA Cancer J Clin201161421223621685461
  • BoylePLevinBWorld Cancer Report 2008Lyon, FranceIARC Press2008
  • TravisWDPathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart7Lyon, FranceIARC Press2004
  • RudominaDELinOMoreiraALCytologic diagnosis of pulmonary adenocarcinoma with micropapillary pattern: does it correlate with the histologic findings?Diagn Cytopathol200937533333919191297
  • KobayashiNToyookaSIchimuraKNon-BAC component but not epidermal growth factor receptor gene mutation is associated with poor outcomes in small adenocarcinoma of the lungJ Thorac Oncol20083770471018594314
  • KamiyaKHayashiYDouguchiJHistopathological features and prognostic significance of the micropapillary pattern in lung adenocar-cinomaMod Pathol2008218992100118516041
  • TomitaMAyabeTChosaEKawagoeKNakamuraKEpidermal growth factor receptor mutations in Japanese men with lung adenocarcinomasAsian Pac J Cancer Prev20141524106271063025605150
  • TravisWDBrambillaENoguchiMInternational association for the study of lung cancer/American Thoracic Society/European Respiratory Society international multidisciplinary classification of lung adenocarcinomaJ Thorac Oncol20116224428521252716
  • WarthAMuleyTMeisterMThe novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survivalJ Clin Oncol201230131438144622393100
  • YoshizawaAMotoiNRielyGJImpact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I casesMod Pathol201124565366421252858
  • Mendonca-PreviatoLPenhaLGarcezTCJonesCPreviatoJOAddition of alpha-O-GlcNAc to threonine residues define the post-translational modification of mucin-like molecules in Trypanosoma cruziGlycoconj J201330765966623430107
  • BennettEPMandelUClausenHGerkenTAFritzTATabakLAControl of mucin-type O-glycosylation: a classification of the polypeptide GalNAc-transferase gene familyGlycobiology201222673675622183981
  • ChakrabortySBonthuNSwansonBJBatraSKRole of mucins in the skin during benign and malignant conditionsCancer Lett2011301212714121146919
  • ShibaoKIzumiHNakayamaYExpression of UDP-N-acetyl-alpha-D-galactosamine-polypeptide galNAc N-acetylgalactosaminyl transferase-3 in relation to differentiation and prognosis in patients with colorectal carcinomaCancer20029471939194611932895
  • Dosaka-AkitaHKinoshitaIYamazakiKN-acetylgalactosaminyl transferase-3 is a potential new marker for non-small cell lung cancersBr J Cancer200287775175512232759
  • NomotoMIzumiHIseTStructural basis for the regulation of UDP-N-acetyl-alpha-D-galactosamine: polypeptide N-acetylgalactosaminyl transferase-3 gene expression in adenocarcinoma cellsCancer Res199959246214622210626815
  • MochizukiYItoKIzumiHKohnoKAmanoJExpression of polypeptide N-acetylgalactosaminyl transferase-3 and its association with clinicopathological factors in thyroid carcinomasThyroid201323121553156023659732
  • KitadaSYamadaSKumaAPolypeptide N-acetylgalactosaminyl transferase 3 independently predicts high-grade tumours and poor prognosis in patients with renal cell carcinomasBr J Cancer2013109247248123799843
  • TaniuchiKCernyRLTanouchiAOverexpression of GalNAc-transferase GalNAc-T3 promotes pancreatic cancer cell growthOncogene201130494843485421625220
  • KatoKTakeuchiHKanohALoss of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 3 and reduced O-glycosylation in colon carcinoma cells selected for hepatic metastasisGlycoconj J201027226727620077002
  • IshikawaMKitayamaJKohnoKNagawaHThe expression pattern of UDP-N-acetyl-alpha-D-galactosamine-polypeptide N-acetyl-galactosaminyl transferase-3 in squamous cell carcinoma of the esophagusPathobiology200572313914515860931
  • GuCOyamaTOsakiTLow expression of polypeptide GalNAc N-acetylgalactosaminyl transferase-3 in lung adenocarcinoma: impact on poor prognosis and early recurrenceBr J Cancer200490243644214735190
  • SobinLHGospodarowiczMKWittekindCTNM Classification of Malignant TumoursNew York, NYJohn Wiley & Sons2011
  • Ambrosini-SpaltroARuiuASeebacherCImpact of the IASLC/ATS/ERS classification in pN0 pulmonary adenocarcinomas: a study with radiological-pathological comparisons and survival analysesPathol Res Pract20142101404624211161
  • SicaGYoshizawaASimaCSA grading system of lung adenocar-cinomas based on histologic pattern is predictive of disease recurrence in stage I tumorsAm J Surg Pathol20103481155116220551825
  • WangZQBachvarovaMMorinCRole of the polypeptide N-acetylgalactosaminyltransferase 3 in ovarian cancer progression: possible implications in abnormal mucin O-glycosylationOncotarget20145254456024504219
  • YoshimuraYNudelmanASLeverySBElucidation of the sugar recognition ability of the lectin domain of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 3 by using unnatural glycopeptide substratesGlycobiology201222342943822042768
  • YimJZhuL-CChiribogaLWatsonHNGoldbergJDMoreiraALHistologic features are important prognostic indicators in early stages lung adenocarcinomasMod Pathol200720223324117192789